Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 1/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.51 |
| ▸ | P2RY1 | P47900 | 6/20 | 0.51 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.49 |
| ▸ | P2RY11 | Q96G91 | 3/20 | 0.49 |
| ▸ | IMPDH2 | P12268 | 5/20 | 0.47 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.47 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.47 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.47 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | FBP1 | P09467 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.47 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.47 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1532393 | 0.99 | P2RX3 (0.57) | P2RX3ADORA1P2RY1ENPP1ADORA3 | |
| SCHEMBL316942 | 0.99 | P2RX3 (0.57) | P2RX3ADORA1P2RY1ENPP1ADORA3 | |
| Water SCHEMBL20266269 | 0.98 | P2RX3 (0.56) | P2RX3ADORA1P2RY1ENPP1ADORA3 | |
| SCHEMBL2683124 | 0.90 | P2RX3 (0.61) | P2RX3ADORA1P2RY1P2RY11IMPDH2 | |
| SCHEMBL184241 | 0.90 | P2RX3 (0.61) | P2RX3ADORA1P2RY1P2RY11IMPDH2 | |
| SCHEMBL4356525 | 0.86 | P2RX3 (0.67) | P2RX3P2RY1ENPP1P2RY11TRPM2 | |
| SCHEMBL4368535 | 0.86 | P2RX3 (0.67) | P2RX3P2RY1ENPP1P2RY11TRPM2 | |
| SCHEMBL24059927 | 0.85 | P2RX3 (0.70) | P2RX3P2RY1ENPP1P2RY11TRPM2 | |
| SCHEMBL4356292 | 0.85 | P2RX3 (0.70) | P2RX3P2RY1ENPP1P2RY11TRPM2 | |
| SCHEMBL4363134 | 0.85 | P2RX3 (0.70) | P2RX3P2RY1ENPP1P2RY11TRPM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12582134-B2 | Non-dairy creamer and method of making the same | CARGILL, INCORPORATED (US) | 2026-03-24 | — | — | US | claimed |
| EP-4642246-A2 | METHODS AND SYSTEMS FOR INDUCING COALESCENCE OF FUNGAL PROTEINS, AND FUNGAL FOOD PRODUCTS MADE THEREBY | The Fynder Group, Inc. (US) | 2025-11-05 | — | — | EP | claimed |
| WO-2025097045-A1 | COLLOIDAL FOOD BASE COMPOSITIONS COMPRISING MYCELIAL BIOMASS | THE FYNDER GROUP, INC (US) | 2025-05-08 | — | — | WO | claimed |
| US-20240324640-A1 | METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY | ALMENDRA PTE LTD (SG) | 2024-10-03 | — | — | US | claimed |
| WO-2024145613-A2 | METHODS AND SYSTEMS FOR INDUCING COALESCENCE OF FUNGAL PROTEINS, AND FUNGAL FOOD PRODUCTS MADE THEREBY | THE FYNDER GROUP, INC. (US) | 2024-07-04 | — | — | WO | claimed |
| US-20240041078-A1 | METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY | ALMENDRA PTE LTD (SG) | 2024-02-08 | — | — | US | claimed |
| EP-4282282-A2 | METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY | Almendra Pte. Ltd. (SG) | 2023-11-29 | — | — | EP | claimed |
| EP-4009810-B1 | METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY | ALMENDRA PTE LTD (SG) | 2023-06-21 | — | — | EP | claimed |
| US-20230183600-A1 | METHOD FOR PRODUCING FISH OIL | MPF, INC. (US) | 2023-06-15 | — | — | US | claimed |
| EP-4149274-A1 | METHOD FOR PRODUCING FISH OIL | MPF, INC. (US) | 2023-03-22 | — | — | EP | claimed |
| EP-2464362-B1 | PROBIOTIC PREPARATION FOR THE PREVENTION OR TREATMENT OF CANINE GASTROINTESTINAL DISORDERS | VETCARE OY (FI) | 2019-09-11 | — | — | EP | claimed |
| WO-2019150004-A1 | HEALTH BENEFICIAL COMPOSITION COMPRISING LACTOBACILLUS AND METHOD FOR THE PREPARATION THEREOF | VETCARE OY (FI) | 2019-08-08 | — | — | WO | claimed |
| US-9095160-B2 | Probiotic preparation for the prevention or treatment of canine gastrointestinal disorders | VETCARE OY (FI) | 2015-08-04 | — | — | US | claimed |
| EP-2515822-A1 | SINGLE-USE CONTAINERS AND USES THEREOF | BM Gol Pty Ltd (AU) | 2012-10-31 | — | — | EP | claimed |
| US-20120201796-A1 | PROBIOTIC PREPARATION FOR THE PREVENTION OR TREATMENT OF CANINE GASTROINTESTINAL DISORDERS | VETCARE OY (FI) | 2012-08-09 | — | — | US | claimed |
| EP-2464362-A1 | PROBIOTIC PREPARATION FOR THE PREVENTION OR TREATMENT OF CANINE GASTROINTESTINAL DISORDERS | Vetcare OY (FI) | 2012-06-20 | — | — | EP | claimed |
| WO-2011075798-A1 | SINGLE-USE CONTAINERS AND USES THEREOF | BM GOL PTY LTD (AU) | 2011-06-30 | — | — | WO | claimed |
| WO-2011018547-A1 | PROBIOTIC PREPARATION FOR THE PREVENTION OR TREATMENT OF CANINE GASTROINTESTINAL DISORDERS | VETCARE OY (FI) | 2011-02-17 | — | — | WO | claimed |
| US-6858244-B2 | Seasoning compositions, foods and drinks with the use thereof and processes for producing the same | AJINOMOTO CO., INC. (JP) | 2005-02-22 | — | — | US | claimed |
| US-20030198723-A1 | Seasoning compositions, foods and drinks with the use thereof and processes for producing the same | AJINOMOTO CO., INC. (JP) | 2003-10-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582134-B2 | Non-dairy creamer and method of making the same | CPT1B, FABP4, SCD | P2RX3 4876/4885ADORA1 3611/4885P2RY1 4763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.